Ghent University Academic Bibliography

Advanced

What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series

Giorgio Gandaglia, Guillaume Ploussard, Henrik Isbarn, Nazareno Suardi, Pieter De Visschere UGent, Jurgen J Fütterer, Pirus Ghadjar, Christophe Massard, Piet Ost UGent, Prasanna Sooriakumaran, et al. (2015) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 33(4). p.164.e1-164.e9
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
Prostate cancer, Active surveillance, Radical prostatectomy, Biochemical recurrence, Oncologic outcomes, RADICAL PROSTATECTOMY, TERM OUTCOMES, BIOPSY, SELECTION, CRITERIA, PROTOCOLS, NUMBER, PRIAS, MEN
journal title
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Urol. Oncol.-Semin. Orig. Investig.
editor
Brian I Rini
volume
33
issue
4
issue title
Dosing/Selecting therapy per individual pt characteristics
pages
164.e1 - 164.e9
Web of Science type
Article
Web of Science id
000391152200004
JCR category
UROLOGY & NEPHROLOGY
JCR impact factor
2.921 (2015)
JCR rank
19/77 (2015)
JCR quartile
1 (2015)
ISSN
1078-1439
DOI
10.1016/j.urolonc.2014.12.011
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
6843532
handle
http://hdl.handle.net/1854/LU-6843532
date created
2015-06-23 11:38:54
date last changed
2017-03-31 13:31:05
@article{6843532,
  author       = {Gandaglia, Giorgio and Ploussard, Guillaume and Isbarn, Henrik and Suardi, Nazareno and De Visschere, Pieter and F{\"u}tterer, Jurgen J and Ghadjar, Pirus and Massard, Christophe and Ost, Piet and Sooriakumaran, Prasanna and Surcel, Christian I and van den Bergh, Roderick CN and Montorsi, Francesco and Ficarra, Vicenzo and Giannarini, Gianluca and Briganti, Alberto},
  editor       = {Rini, Brian I},
  issn         = {1078-1439},
  journal      = {UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS},
  keyword      = {Prostate cancer,Active surveillance,Radical prostatectomy,Biochemical recurrence,Oncologic outcomes,RADICAL PROSTATECTOMY,TERM OUTCOMES,BIOPSY,SELECTION,CRITERIA,PROTOCOLS,NUMBER,PRIAS,MEN},
  language     = {eng},
  number       = {4},
  pages        = {164.e1--164.e9},
  title        = {What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series},
  url          = {http://dx.doi.org/10.1016/j.urolonc.2014.12.011},
  volume       = {33},
  year         = {2015},
}

Chicago
Gandaglia, Giorgio, Guillaume Ploussard, Henrik Isbarn, Nazareno Suardi, Pieter De Visschere, Jurgen J Fütterer, Pirus Ghadjar, et al. 2015. “What Is the Optimal Definition of Misclassification in Patients with Very Low-risk Prostate Cancer Eligible for Active Surveillance? : Results from a Multi-institutional Series.” Ed. Brian I Rini. Urologic Oncology-seminars and Original Investigations 33 (4): 164.e1–164.e9.
APA
Gandaglia, G., Ploussard, G., Isbarn, H., Suardi, N., De Visschere, P., Fütterer, J. J., Ghadjar, P., et al. (2015). What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series. (B. I. Rini, Ed.)UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 33(4), 164.e1–164.e9.
Vancouver
1.
Gandaglia G, Ploussard G, Isbarn H, Suardi N, De Visschere P, Fütterer JJ, et al. What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series. Rini BI, editor. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2015;33(4):164.e1–164.e9.
MLA
Gandaglia, Giorgio, Guillaume Ploussard, Henrik Isbarn, et al. “What Is the Optimal Definition of Misclassification in Patients with Very Low-risk Prostate Cancer Eligible for Active Surveillance? : Results from a Multi-institutional Series.” Ed. Brian I Rini. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 33.4 (2015): 164.e1–164.e9. Print.